PRPH Competitors & Alternatives
Compare ProPhase Labs Inc with similar stocks in the same industry
Diagnostics & Research
PRPH
Main Stock$0.36
Tradestie Score
40
Market Cap
$21.41M
Revenue Growth
-0.4%
Analyst Upside
+3705.8%
Top Competitors
39 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NEO
NeoGenomics, Inc.
|
$18.67
|
$1.13B | - | 31 | Compare |
|
CDNA
CareDx, Inc.
|
$63.51
|
$798.40M | 30.6 | 37 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$22.09
|
$719.31M | - | 40 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$34.73
|
$667.77M | - | 36 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$16.22
|
$612.76M | - | 53 | Compare |
|
ICCC
Immucell Corp
|
$9.97
|
$59.70M | 141.8 | 50 | Compare |
|
CPIX
Cumberland Pharmaceuticals Inc
|
$7.75
|
$46.68M | - | 36 | Compare |
|
NAII
Natural Alternatives International Inc.
|
$1.60
|
$17.91M | - | 38 | Compare |
|
XTLB
XTL Biopharmaceuticals Ltd. American Depositary Shares
|
$2.24
|
$10.14M | - | 52 | Compare |
|
SNOA
Sonoma Pharmaceuticals, Inc. Common Stock
|
$1.28
|
$6.37M | - | 62 | Compare |
More PRPH Analysis
Data updated: Sep 29, 2026 | Industry: Diagnostics & Research (SIC 2834)
39 stocks in this industry